Brian Fuehrlein, MD, PhD
Associate Professor of PsychiatryCards
About
Research
Publications
2024
Harm Reduction Treatment for Substance Use
by: R, Fuehrlein B. Harm Reduction Treatment for Substance Use. Journal Of Psychiatric Practice 2024, 30: 385-385. PMID: 39357022, DOI: 10.1097/pra.0000000000000805.Peer-Reviewed Original ResearchA detox dilemma beyond benzodiazepines; clonidine's quandary in alcohol withdrawal management
Johnson M, Cosentino D, Fuehrlein B. A detox dilemma beyond benzodiazepines; clonidine's quandary in alcohol withdrawal management. American Journal On Addictions 2024 PMID: 39096168, DOI: 10.1111/ajad.13640.Peer-Reviewed Original ResearchPsychiatric emergency roomAlcohol withdrawalBenzodiazepine useAmerican Society of Addiction Medicine guidelinesTreatment of alcohol withdrawalClinical Institute Withdrawal AssessmentAWS managementAlternative agentsComorbid hypertensionEmergency roomVeterans AffairsRetrospective chart reviewWithdrawal AssessmentOpioid withdrawalBenzodiazepine doseAdjunctive medicationsAlcohol withdrawal managementBenzodiazepinesWithdrawal managementDepartment of Veterans AffairsVeteran populationClonidine useMedication dosesChart reviewSyndromic managementA Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder
Celik M, Gold M, Fuehrlein B. A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder. Brain Sciences 2024, 14: 294. PMID: 38539681, PMCID: PMC10969323, DOI: 10.3390/brainsci14030294.Peer-Reviewed Original ResearchAlcohol use disorderUse disorderTreatment of alcohol use disordersGLP-1 receptor agonistsCurrent treatment landscapeAlcohol withdrawal syndromePhosphodiesterase-4 inhibitorWithdrawal syndromeTreatment landscapeReceptor agonistsTreatment modalitiesGlobal disease burdenPhosphodiesterase-4GLP-1Disease burdenNarrative reviewDisordersAnnual deathsMedicationTreatmentAlcoholPsychotherapyPsychedelicsHealth conditionsOpioid use disorder: current trends and potential treatments
Lee Y, Gold M, Blum K, Thanos P, Hanna C, Fuehrlein B. Opioid use disorder: current trends and potential treatments. Frontiers In Public Health 2024, 11: 1274719. PMID: 38332941, PMCID: PMC10850316, DOI: 10.3389/fpubh.2023.1274719.Peer-Reviewed Original ResearchConceptsOpioid use disorderNovel approaches to treatmentTreatment of opioid use disorderComorbid disordersRemitting disorderApproach to treatmentMedication treatment of opioid use disorderUse disorderSubstance useInterventional treatmentPublic health threatFDA approvalTreatment approachesBuprenorphine prescribingHarm reduction strategiesMedical treatmentMedical conditionsDisordersOverdoseLess stigmaTreatmentOverdose deathsElectromagnetic therapyDeathReduce overdosesAnalysis of nonfatal suicide attempts and demographic characteristics of US military veterans with opioid use disorder: A descriptive VA medical center study
Celik M, Cosentino D, Fuehrlein B. Analysis of nonfatal suicide attempts and demographic characteristics of US military veterans with opioid use disorder: A descriptive VA medical center study. American Journal On Addictions 2024, 33: 347-350. PMID: 38273434, DOI: 10.1111/ajad.13519.Peer-Reviewed Original ResearchPrevalence of comorbid psychiatric conditionsVA Medical CenterCohort of veteransSuicide attemptsUS military veteransTreat OUDNonfatal suicide attemptsOpioid use disorderLifetime suicide attempt ratePrevent suicideHousing instabilityMilitary veteransVeteransDemographic characteristicsComorbid psychiatric conditionsLifetime suicide attemptsOUD diagnosisMedical CenterSuicide attempt rateHigh riskUse disorderPsychiatric conditionsPatient populationAttempt rateOUD
2023
US Medicaid program: An analysis of the spending and utilization patterns for antidepressants from 2017 to 2021
Elmarasi M, Fuehrlein B. US Medicaid program: An analysis of the spending and utilization patterns for antidepressants from 2017 to 2021. Exploratory Research In Clinical And Social Pharmacy 2023, 13: 100392. PMID: 38149102, PMCID: PMC10750172, DOI: 10.1016/j.rcsop.2023.100392.Peer-Reviewed Original ResearchMajor depressive disorderMonoamine oxidase inhibitorsTricyclic antidepressantsDepressive disorderCommon mental health concernsStudy periodClasses of antidepressantsMedicaid programUS Medicaid programMental health conditionsSerious mental health conditionsPublic health systemMental health concernsAntidepressant prescriptionsSingle antidepressantTreatment patternsAntidepressant usagePrescription dataMedicaid dataUS adultsAntidepressantsHealth complicationsLifetime diagnosisOxidase inhibitorsHealth system
2020
Simulation in Addiction Education
Jaeger S, Fuehrlein B. Simulation in Addiction Education. Current Treatment Options In Psychiatry 2020, 7: 570-575. DOI: 10.1007/s40501-020-00226-8.Peer-Reviewed Original Research
2014
A Prospective Study of the Associations Among Housing Status and Costs of Services in a Homeless Population
Fuehrlein BS, Cowell AJ, Pollio D, Cupps L, Balfour ME, North CS. A Prospective Study of the Associations Among Housing Status and Costs of Services in a Homeless Population. Psychiatric Services 2014, 66: 27-32. PMID: 25269783, PMCID: PMC8448415, DOI: 10.1176/appi.ps.201400010.Peer-Reviewed Original Research
2013
Deriving costs of service use among an urban homeless population
Fuehrlein BS, Cowell AJ, Pollio DE, Cupps LY, Balfour ME, North CS. Deriving costs of service use among an urban homeless population. Journal Of Substance Use And Addiction Treatment 2013, 46: 491-497. PMID: 24462220, PMCID: PMC3962616, DOI: 10.1016/j.jsat.2013.12.002.Peer-Reviewed Original ResearchCharacteristics and drinking patterns of veterans with alcohol dependence with and without post-traumatic stress disorder
Fuehrlein B, Ralevski E, O'Brien E, Jane JS, Arias AJ, Petrakis IL. Characteristics and drinking patterns of veterans with alcohol dependence with and without post-traumatic stress disorder. Addictive Behaviors 2013, 39: 374-378. PMID: 24090619, DOI: 10.1016/j.addbeh.2013.08.026.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdrenergic alpha-AntagonistsAdultAgedAlcohol DrinkingAlcoholismComorbidityConnecticutDiagnosis, Dual (Psychiatry)FemaleHumansMaleMassachusettsMecamylamineMental DisordersMiddle AgedNicotinic AntagonistsPlacebosPrazosinPsychotropic DrugsSeverity of Illness IndexStress Disorders, Post-TraumaticSubstance-Related DisordersTreatment OutcomeVeteransYoung AdultConceptsPost-traumatic stress disorderCo-occurring illnessesAlcohol dependenceStress disorderCo-occurring alcohol dependenceDetailed drinking historiesDifferent treatment studiesMajor depressive episodeClinical treatment settingsHeavy drinking daysAlcohol use disorderPre-treatment characteristicsBaseline characteristicsDepressive episodePsychiatric symptomsUse disordersDrinking daysDomains of psychopathologyTreatment settingsDrinking historyTreatment studiesPsychopathological domainsPTSD groupPTSD symptomsMore days
Academic Achievements & Community Involvement
News
News
- December 12, 2024
Fuehrlein, Pérez Palmer, Wilkins Promoted at VA
- August 27, 2024Source: Psychology Today
Smoking Hard Drugs Is Now Killing Many Users
- April 02, 2024
Fuehrlein Appointed Chief Mental Health Consultant at VA Central Office
- February 28, 2024Source: Psychology Today
Ask the Expert: An Interview With Yale's Brian Fuehrlein, MD, PhD